A phase I open-label, multi-dose escalation study of the dual Syk/Jak inhibitor PRT062070 (cerdulatinib) in patients with relapsed/refractory B cell malignancies Meeting Abstract
| Authors: | Patel, M.; Hamlin, P.; Strickland, D. K.; Pandey, A.; Coffey, G.; Leeds, J. M.; Levy, G. G.; Curnutte, J. T.; Wagner-Johnston, N.; Flinn, I. W. |
| Abstract Title: | A phase I open-label, multi-dose escalation study of the dual Syk/Jak inhibitor PRT062070 (cerdulatinib) in patients with relapsed/refractory B cell malignancies |
| Meeting Title: | 56th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 124 |
| Issue: | 21 |
| Meeting Dates: | 2014 Dec 6-9 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2014-12-06 |
| Language: | English |
| ACCESSION: | WOS:000349243504159 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V124.21.3103.3103 |
| Notes: | Meeting Abstract: 3103 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos |
